<SUBMISSION>
<ACCESSION-NUMBER>0000950153-05-000699
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20050401
<ITEMS>2.02
<ITEMS>9.01
<FILING-DATE>20050401
<DATE-OF-FILING-DATE-CHANGE>20050401
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>TASER INTERNATIONAL INC
<CIK>0001069183
<ASSIGNED-SIC>3480
<IRS-NUMBER>860741227
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-16391
<FILM-NUMBER>05725934
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7860 EAST MCLAIN DR.
<STREET2>SUITE 2
<CITY>SCOTTSDALE
<STATE>AZ
<ZIP>85260
<PHONE>4809052000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7860 EAST MCLAIN DR.
<STREET2>SUITE 2
<CITY>SCOTTSDALE
<STATE>AZ
<ZIP>85260
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>p70440e8vk.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>Washington, DC 20549</B>
</DIV>


<P align="center" style="font-size: 10pt"><HR size="1" noshade width="26%" align="center" color="#000000">


<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>


<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of<BR>
The Securities Exchange Act of 1934</B>


<P align="center" style="font-size: 10pt">Date of Report (Date of earliest event reported)



<P align="center" style="font-size: 10pt"><B>April&nbsp;1, 2005</B>



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="26%" align="center" color="#000000">


<P align="center" style="font-size: 24pt"><B>TASER International, Inc.</B>


<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of<BR>
incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>001-16391</B><BR>
(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>86-0741227</B><BR>
(IRS Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><B>7860 E. McClain Drive, Suite&nbsp;2<BR>
Scottsdale, Arizona 85260</B><BR>
(Address of principal executive offices, including zip code)



<P align="center" style="font-size: 10pt"><B>(480)&nbsp;991-0791</B><BR>
(Registrant&#146;s telephone number, including area code)



<P align="center" style="font-size: 10pt">(Former name or former address, if changed since last report)


<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:


<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)


<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)


<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))


<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))



<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="left" style="font-size: 10pt"><B>Item&nbsp;2.02. Results of Operations and Financial Condition.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attached hereto as Exhibit&nbsp;99.1 and incorporated by reference herein is the text of the
registrant&#146;s press release, dated April&nbsp;1, 2005, regarding preliminary financial results for the
registrant&#146;s first fiscal quarter ended March&nbsp;31, 2005.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information in this Current Report on Form 8-K is being furnished and shall not be deemed
&#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that Section.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01. Financial Statements and Exhibits.</B>



<P align="left" style="font-size: 10pt"><B>(c)&nbsp;Exhibits.</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated April&nbsp;1, 2005</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TASER INTERNATIONAL, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ DANIEL BEHRENDT
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Daniel Behrendt&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Date: April&nbsp;1, 2005




<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated April&nbsp;1, 2005</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>p70440exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<P align="right" style="font-size: 10pt">EXHIBIT 99.1



<P align="center" style="font-size: 14pt"><B>TASER International, Inc. Releases Preliminary First Quarter Sales<BR>
Results</B>


<P align="center" style="font-size: 10pt"><B><I>Company Estimates First Quarter Revenue of Approximately $10 Million</I></B>


<P align="left" style="font-size: 10pt">SCOTTSDALE, Ariz., April&nbsp;1, 2005 &#151; TASER International, Inc. (Nasdaq: TASR), a market leader in
advanced non-lethal devices announced today that it estimates first quarter revenue of
approximately $10&nbsp;million.


<P align="left" style="font-size: 10pt">&#147;As outlined in our shareholder letter at the beginning of the quarter and in our February
conference call, significant adverse publicity in the first quarter has caused what we believe to
be a temporary disruption in our sales pipeline,&#148; commented Rick Smith, Chief Executive Officer of
TASER International, Inc. &#147;Accordingly, we decided not to issue financial guidance because of the
lack of visibility on our business in light of this controversy. Consequently, we did experience a
significant disruption in the flow of new business in the first quarter.&#148;


<P align="left" style="font-size: 10pt">&#147;The first quarter also brought answers to many of the inquiries regarding the safety of TASER&#153;
products. Independent reports on TASER safety have been released from the Home Office of the
United Kingdom, the Potomac Institute for Policy Studies, and the United States Department of
Defense Human Effects Center of Excellence. These studies have supported the view that TASER
devices, while not risk free, are generally safe and reduce the risk of injury or death.
Coincidentally, the U.S. Food and Drug Administration (FDA)&nbsp;utilizes a similar approach to the risk
management of devices within its jurisdiction. The FDA states that, &#145;although medical products are
required to be safe, safety does not mean zero risk, since all medical products are associated with
risks. A safe medical product is one that has reasonable risks given the magnitude of the benefit
expected and the alternatives available.&#146; Similarly, the safety of TASER devices must be evaluated
in the context of alternative force options,&#148; continued Smith.


<P align="left" style="font-size: 10pt">&#147;In order to address these challenges, we have implemented a tactical plan that focuses on two key
elements:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="10%" style="background: transparent">&nbsp;</TD>
    <TD width="4%" nowrap align="left">1.&nbsp;&nbsp;</TD>
    <TD>We have assembled a team of experts to advise the company on public education and
public relations issues. TASER has successfully begun to vigorously defend against the
myriad of erroneous and misleading information in the public domain with data and testimony
whenever requested.</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="10%" style="background: transparent">&nbsp;</TD>
    <TD width="4%" nowrap align="left">2.&nbsp;&nbsp;</TD>
    <TD>We have launched a customer and public education campaign that includes the largest
user conference in company history in April, as well as the distribution of safety
information to almost 100,000 police and medical opinion leaders, coupled with personal
visits by senior TASER management to key existing customers and prospective new accounts.</TD>
</TR>

</TABLE>

<P align="left" style="font-size: 10pt">&#147;Most importantly, we continue to receive strong support from our installed customer base, and the
results of field use of our products continue to receive praise from end users. Also, it is

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt">important to note that public support for both police and private citizen use of TASER devices
remains very high. Polls from Zogby, the Arizona Republic, NBC, CNBC, and other newspapers found
public support for TASER use ranged from 63% to 90% of respondents. Accordingly, we remain
confident in our long term business prospects despite the short term challenges. TASER
International is blessed with a great team of dedicated people who have overcome and excelled
during tough times in our past. I am confident we will rise to the current challenges and overcome
them again,&#148; concluded Smith.



<P align="left" style="font-size: 10pt"><B>About TASER International, Inc.</B>


<P align="left" style="font-size: 10pt">TASER International, Inc. provides advanced non-lethal devices for use in the law enforcement,
military, private security and personal defense markets. TASER devices use proprietary technology
to safely incapacitate dangerous, combative or high-risk subjects who pose a risk to law
enforcement officers, innocent citizens or themselves. TASER technology saves lives every day, and
the use of TASER devices dramatically reduces injury rates for police officers and suspects and
reduces litigation costs. For more information on TASER life-saving technology, please call TASER
International at (800)&nbsp;978-2737 or visit our website at
<U>www.TASER.com</U>.



<P align="left" style="font-size: 10pt"><B>Note to Investors</B>


<P align="left" style="font-size: 10pt">This press release contains forward-looking information within the meaning of Section&nbsp;27A of the
Securities Act of the 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934, and is subject
to the safe harbor created by those sections. The forward-looking information is based upon current
information and expectations regarding TASER International. These estimates and statements speak
only as of the date on which they are made, are not guarantees of future performance, and involve
certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual
outcomes and results could materially differ from what is expressed, implied, or forecasted in such
forward-looking statements.


<P align="left" style="font-size: 10pt">TASER International assumes no obligation to update the information contained in this press
release. TASER International&#146;s future results may be impacted by risks associated with rapid
technological change, new product introductions, new technological developments and
implementations, execution issues associated with new technology, ramping manufacturing production
to meet demand, litigation including lawsuits resulting from alleged product related injuries,
media publicity concerning allegations of deaths occurring after use of the TASER device and the
negative impact this could have on sales, product quality, implementation of manufacturing
automation, potential fluctuations in quarterly operating results, competition, financial and
budgetary constraints of prospects and customers, international order delays, dependence upon sole
and limited source suppliers, negative reports concerning TASER device uses, governmental inquiries
and investigations, medical and safety studies, fluctuations in component pricing, government
regulations, variation among law enforcement agencies with their TASER product experience, TASER
device tests and reports, dependence upon key employees, and our ability to retain employees. TASER
International&#146;s future results may also be impacted by other risk factors listed from time to time
in its SEC filings, including, but not limited to, the Company&#146;s Form 10-QSBs and its Annual Report
on Form 10-KSB.


<P align="left" style="font-size: 10pt">The revenue number referenced herein is preliminary and is subject to changes resulting from any
accounting adjustments made to these preliminary results as our quarterly results are finalized.
We expect to report our final results for the first quarter on April&nbsp;19, 2005.


<P align="left" style="font-size: 10pt">No conference call will be held in connection with this press release.



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<P align="left" style="font-size: 10pt">The statements made herein are independent statements of TASER International. The inclusion
of any third parties does not represent an endorsement of any TASER International products or
services by any such third parties


<P align="left" style="font-size: 10pt">For further information contact Rick Smith, Chief Executive Officer, (480)&nbsp;905-2000. Visit the
company&#146;s web-site at <U>www.TASER.com</U> for facts and video.



<P align="center" style="font-size: 10pt"># # #




<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
